Univerzitná nemocnica - Nemocnica svätého Michala, a. s
- Address
- Cintorinska 3a, 811 08 Bratislava, Slovakia
Univerzitná nemocnica - Nemocnica svätého Michala, a.s
Univerzitná nemocnica - Nemocnica svätého Michala, a.s is a university hospital actively engaged in clinical research focused on autoimmune and rheumatological conditions. The institution participates in international multicenter trials investigating innovative therapeutic approaches for chronic systemic diseases.
- Long-term safety and efficacy studies in autoimmune disorders
- Novel biologic therapies for Sjögren's syndrome
- Randomized controlled trials in rheumatology
The center demonstrates particular expertise in Sjögren's syndrome research, contributing to extension studies that evaluate the sustained safety and tolerability of immunomodulatory treatments. This involvement in longitudinal research protocols reflects the institution's commitment to advancing understanding of chronic autoimmune conditions and improving long-term patient outcomes through evidence-based therapeutic interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novartis Pharma AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG4trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Univerzitná nemocnica - Nemocnica svätého Michala, a. s
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Atogepant in Acute Migraine Treatment: A Randomized, Double-Blind, Placebo-Controlled Study | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Apr 2024 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ianalumab | 4 | Unknown | 2022-08-04 | 2024-05-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.